Relapsed/Refractory Large B Cell Lymphoma
Oncology
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Allogene TherapeuticsSOUTH SAN FRANCISCO, CA
2 programs1
1
ALLO-647Phase 21 trial
ALLO-501Phase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Allogene TherapeuticsALLO-647
Allogene TherapeuticsALLO-501
Clinical Trials (2)
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy
Start: Nov 2023Est. completion: Oct 2024
Phase 2Terminated
Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma
Start: May 2019Est. completion: Jan 2025
Phase 1Completed
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
8m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
8m ago
Office Administrator
SystImmune
9m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
19m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
23m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
23m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space